sb 203580 has been researched along with furafylline in 1 studies
| Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (furafylline) | Trials (furafylline) | Recent Studies (post-2010) (furafylline) |
|---|---|---|---|---|---|
| 3,489 | 4 | 1,137 | 121 | 2 | 42 |
| Protein | Taxonomy | sb 203580 (IC50) | furafylline (IC50) |
|---|---|---|---|
| Cytochrome P450 1A2 | Homo sapiens (human) | 2.5292 | |
| Cytochrome P450 2C19 | Homo sapiens (human) | 0.3 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Antonios, D; Gautier, JC; Lacour, S; Pallardy, M | 1 |
1 other study(ies) available for sb 203580 and furafylline
| Article | Year |
|---|---|
Acetaminophen and lipopolysaccharide act in synergy for the production of pro-inflammatory cytokines in murine RAW264.7 macrophages.
Topics: Acetaminophen; Animals; Anthracenes; Cell Line; Cytochrome P-450 CYP1A2 Inhibitors; Drug Synergism; Extracellular Signal-Regulated MAP Kinases; Flavonoids; Imidazoles; Indomethacin; Interleukin-1beta; Lipopolysaccharides; Macrophages; MAP Kinase Kinase 1; MAP Kinase Kinase 4; Mice; p38 Mitogen-Activated Protein Kinases; Prostaglandin-Endoperoxide Synthases; Pyridines; Signal Transduction; Theophylline; Tumor Necrosis Factor-alpha | 2009 |